Multiple Manufacturers

DAUNORUBICIN HCL

Manufacturer:

Multiple Manufacturers

Daunorubicin Hcl HCPCS:

J9150

HCPCS Code Descriptor:

Injection, daunorubicin, 10 mg

Category:

J Code

Daunorubicin Hcl NDCs:

00143-9551-10, 42658-0021-02, 42658-0021-92, 00143-9550-01, 42658-0021-91, 42658-0021-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

42658-0021-02, 00143-9550-01, 42658-0021-01

About Daunorubicin Hcl:

DAUNORUBICIN HCL is an Oncology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J9150 is aligned to the drug DAUNORUBICIN HCL.

ACCESS PRICING AND MORE BY REGISTERING

J9150 Added Date:

January 1, 1986

J9150 Effective Date:

January 1, 2009

J9150 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Daunorubicin Hcl billing and coding information.
Our team did not identify a source for Daunorubicin Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
DAUNORUBICIN HCL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for DAUNORUBICIN HCL. Please check back in a few weeks.